These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32166009)

  • 1. The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes.
    Lee CL; Chen CH; Wu MJ; Tsai SF
    Ther Adv Chronic Dis; 2020; 11():2040622319898370. PubMed ID: 32166009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore.
    Low S; Lim SC; Yeoh LY; Liu YL; Liu JJ; Fun S; Su C; Zhang X; Subramaniam T; Sum CF
    J Diabetes; 2017 Oct; 9(10):908-919. PubMed ID: 27935225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct association of visit-to-visit HbA1c variation with annual decline in estimated glomerular filtration rate in patients with type 2 diabetes.
    Takenouchi A; Tsuboi A; Terazawa-Watanabe M; Kurata M; Fukuo K; Kazumi T
    J Diabetes Metab Disord; 2015; 14():69. PubMed ID: 26380227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmeal triglyceridemia and variability of HbA1c and postmeal glycemia were predictors of annual decline in estimated glomerular filtration rate in type 2 diabetic patients with different stages of nephropathy.
    Tsuboi A; Takenouchi A; Kurata M; Fukuo K; Kazumi T
    J Diabetes Metab Disord; 2017; 16():1. PubMed ID: 28097106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in the estimated glomerular filtration rate (eGFR) following metabolic control and its relationship with baseline eGFR in type 2 diabetes with microalbuminuria or macroalbuminuria.
    Akazawa S; Sadashima E; Sera Y; Koga N
    Diabetol Int; 2022 Jan; 13(1):148-159. PubMed ID: 35059251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose control, diabetic retinopathy, and hemodialysis induction in subjects with normo-microalbuminuric type 2 diabetic patients with normal renal function followed for 15 years.
    Moriya T; Hayashi A; Matsubara M; Suzuki A; Ouchi M
    J Diabetes Complications; 2022 Jan; 36(1):108080. PubMed ID: 34740544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial.
    Cherney DZI; Cosentino F; Dagogo-Jack S; McGuire DK; Pratley RE; Frederich R; Maldonado M; Liu CC; Pong A; Cannon CP;
    Am J Nephrol; 2022; 53(7):516-525. PubMed ID: 35691283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial.
    Muskiet MHA; Tonneijck L; Huang Y; Liu M; Saremi A; Heerspink HJL; van Raalte DH
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):859-869. PubMed ID: 30292589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial.
    Dagogo-Jack S; Pratley RE; Cherney DZI; McGuire DK; Cosentino F; Shih WJ; Liu J; Frederich R; Mancuso JP; Raji A; Gantz I
    BMJ Open Diabetes Res Care; 2021 Oct; 9(1):. PubMed ID: 34620621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Kawasaki R; Ohashi Y; Akanuma Y; Yamada N; Sone H; Yamashita H; Katayama S;
    Diabetes Care; 2013 Sep; 36(9):2803-9. PubMed ID: 23620478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated Haemoglobin A1c Variability Score Elicits Kidney Function Decline in Chinese People Living with Type 2 Diabetes.
    Zhou Y; Huang H; Yan X; Hapca S; Bell S; Qu F; Liu L; Chen X; Zhang S; Shi Q; Zeng X; Wang M; Li N; Du H; Meng W; Su B; Tian H; Li S; On Behalf Of The WECODe Study Group
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.
    Bethel MA; Mentz RJ; Merrill P; Buse JB; Chan JC; Goodman SG; Iqbal N; Jakuboniene N; Katona B; Lokhnygina Y; Lopes RD; Maggioni AP; Ohman P; Tankova T; Bakris GL; Hernandez AF; Holman RR
    Diabetes Care; 2020 Feb; 43(2):446-452. PubMed ID: 31757838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glucose variability on linear growth in children with type 1 diabetes.
    Blasetti A; Castorani V; Polidori N; Mascioli I; Chiarelli F; Giannini C
    Endocr Connect; 2023 Apr; 12(4):. PubMed ID: 36799250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal insufficiency and its associated factors in type 2 diabetic patients with normoalbuminuria.].
    Lu WN; Li H; Zheng FP; Huang H; Ruan Y
    Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):24-7. PubMed ID: 20356476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria.
    Vistisen D; Andersen GS; Hulman A; Persson F; Rossing P; Jørgensen ME
    Diabetes Care; 2019 Oct; 42(10):1886-1894. PubMed ID: 31221677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visit-to-visit variability in estimated glomerular filtration rate predicts hospitalization and death due to cardiovascular events.
    Suzuki A; Obi Y; Hayashi T; Kotani N; Uemura Y; Imai E; Makino H; Hishida A
    Clin Exp Nephrol; 2019 May; 23(5):661-668. PubMed ID: 30687876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center.
    Sugiyama S; Jinnouchi H; Yoshida A; Hieshima K; Kurinami N; Jinnouchi K; Tanaka M; Suzuki T; Miyamoto F; Kajiwara K; Jinnouchi T
    J Clin Med Res; 2019 Apr; 11(4):267-274. PubMed ID: 30937117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between visit-to-visit variability of HbA
    Yu ZB; Zhu Y; Li D; Wu MY; Tang ML; Wang JB; Chen K
    Diabetologia; 2020 Jan; 63(1):85-94. PubMed ID: 31485707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with the Decline of Kidney Function Differ among eGFR Strata in Subjects with Type 2 Diabetes Mellitus.
    Meguro S; Tomita M; Kabeya Y; Katsuki T; Oikawa Y; Shimada A; Kawai T; Itoh H; Atsumi Y
    Int J Endocrinol; 2012; 2012():687867. PubMed ID: 23316229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.